Cullinan Associates’s Cognex CGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-3,700
Closed -$207K – 245
2023
Q2
$207K Sell
3,700
-600
-14% -$31K 0.01% 247
2023
Q1
$213K Sell
4,300
-100
-2% -$5.06K 0.01% 235
2022
Q4
$207K Buy
+4,400
New +$206K 0.01% 266
2022
Q2
– Sell
-4,400
Closed -$339K – 232
2022
Q1
$339K Hold
4,400
– – 0.02% 201
2021
Q4
$342K Hold
4,400
– – 0.02% 200
2021
Q3
$353K Sell
4,400
-200
-4% -$17.2K 0.02% 198
2021
Q2
$387K Hold
4,600
– – 0.02% 186
2021
Q1
$382K Sell
4,600
-200
-4% -$16.7K 0.02% 173
2020
Q4
$385K Buy
+4,800
New +$349K 0.02% 162

Other funds holding CGNX

Cullinan Associates's CGNX Position: Q3 2023 in Review

Cullinan Associates sold out of Cognex (CGNX) in Q3 2023, closing a stake of 3,700 shares — an estimated $207K sold.

Cullinan Associates first reported a position in CGNX in Q4 2020 and held it in 9 quarters. The position peaked at $387K in Q2 2021. 466 funds tracked by Wall St. Rank hold CGNX as of Q3 2023.

  • Cullinan Associates reported no remaining Cognex position as of Q3 2023 after selling out during the quarter.
  • Cullinan Associates sold 3,700 Cognex shares in Q3 2023, an estimated $207K.
  • Cullinan Associates first reported a position in Cognex in Q4 2020 and held it in 9 quarters.
  • Cullinan Associates's Cognex position peaked at $387K in Q2 2021.
  • 466 funds tracked by Wall St. Rank held Cognex as of Q3 2023.

Based on Cullinan Associates's 13F filing for Q3 2023, filed 11 Oct 2023.